RUFFOLO ROBERT R 4
4 · Sigilon Therapeutics, Inc. · Filed May 22, 2023
Insider Transaction Report
Form 4
RUFFOLO ROBERT R
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-05-19+8,888→ 8,888 totalExercise: $0.64Exp: 2033-05-18→ Common Stock (8,888 underlying)
Footnotes (1)
- [F1]The option was issued pursuant to the Sigilon Therapeutics, Inc. 2020 Equity Incentive Plan. The option will vest as to 100% on May 19, 2024